$WHWK
Whitehawk Therapeutics, Inc.
A volume-weighted average price line from the last reported earnings date through today.
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
- CEO
- Dr. David J. Lennon Ph.D.
- Employees
- 32
- Headquarters
- Morristown, NJ
- Sector
- Healthcare
- Industry
- Biotechnology
- Website
- ir.whitehawktx.com
Key stats
- Market Cap
- $258.82M
- P/E Ratio
- —
- Avg Volume (3M)
- 455.56K
- EPS
- -$1.19
- Day's Range
- $4.44 – $4.59
Fundamentals as of Sep 01, 2026